Innovating Works

OCC

A stranger
MiCCrobioTAckle: Advancing Research at the Intersection Between Gut Microbiota and Cancer Cachexia to Train Europe s... OSLO CANCER CLUSTER SA participó en un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 Microbiota medicine is the new frontier in human health. The human gastrointestinal tract is home to trillions of microbes. Under normal con...
2024-07-05 - 2028-10-31 | financed
INNAXE: Inclusive & aligned INNovation Agendas across Europe OSLO CANCER CLUSTER SA participó en un HORIZON EUROPE: HORIZON-EIE-2021-CONNECT-01 INNAXE aims at strengthening the interconnection and fostering the dialog among European Life Sciences and Healthtech innovation ecosystems,...
2022-06-13 - 2024-06-30 | financed
DIGI-B-CUBE: Digital Enterprise Innovations for Bioimaging Biosensing and Biobanking Industries OSLO CANCER CLUSTER SA processed a H2020: H2020-INNOSUP-2018-2020 DIGI-B-CUBE project aims to unlock the cross-sectoral collaborative potential of SMEs by combining Artificial Intelligence (AI), Cognitive C...
2019-05-08 - 2022-04-30 | financed
PERMIDES: Personsalised Medicine Innovation through Digital Enterprise Solutions OSLO CANCER CLUSTER SA participó en un H2020: H2020-INNOSUP-2014-2015 It is the aim of PERMIDES to strenghten the competitiveness and foster the innovation potential of Personalized Medicine as an Emerging Indu...
2016-06-16 - 2018-08-31 | financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.